Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by American Acne and Rosacea Society (AARS), American Acne, and Rosacea Society (AARS). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Acne and Rosacea Society (AARS), American Acne, and Rosacea Society (AARS) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Mix & Match: Assessing Concomitant Use of Newer Topical Formulations

8:00
 
Share
 

Archived series ("Inactive feed" status)

When? This feed was archived on October 30, 2025 16:16 (2M ago). Last successful fetch was on June 24, 2025 12:14 (6M ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 479945570 series 3570618
Content provided by American Acne and Rosacea Society (AARS), American Acne, and Rosacea Society (AARS). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Acne and Rosacea Society (AARS), American Acne, and Rosacea Society (AARS) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Combination therapy is arguably the norm in acne care, but what do we know about the concomitant use of newer topical treatments? AARS Treasurer Emmy Graber, MD discusses findings from her recent study.
The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!

  continue reading

One episode

Artwork
iconShare
 

Archived series ("Inactive feed" status)

When? This feed was archived on October 30, 2025 16:16 (2M ago). Last successful fetch was on June 24, 2025 12:14 (6M ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 479945570 series 3570618
Content provided by American Acne and Rosacea Society (AARS), American Acne, and Rosacea Society (AARS). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Acne and Rosacea Society (AARS), American Acne, and Rosacea Society (AARS) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Combination therapy is arguably the norm in acne care, but what do we know about the concomitant use of newer topical treatments? AARS Treasurer Emmy Graber, MD discusses findings from her recent study.
The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS by becoming a member!

  continue reading

One episode

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play